9 hours ago
Lupin takes 82.2% stake in Kaveri Therapeutics, licences 2 oncology assets for $1.6mn
Lupin, India's No. 2 drugmaker, spins-out two oncology programmes to Kaveri | Photo Credit: Reuters Global pharma major Lupin has spun-out two oncology programmes to Kaveri Therapeutics Inc for $1..6 million, taking its stake in the U.S.... Read more.
Owner: Jeremy Scahill & Ryan Grim (Founding Editors)
Owner: Robert Duncan through Buzz Future L.L.C.
Owner: British Government through Ofcom
More from The Hindu
Owner: The Kasturi Family through Kasturi & Sons Ltd (KSL) & THG Publishing Pvt. Ltd.
Owner: The Kasturi Family through Kasturi & Sons Ltd (KSL) & THG Publishing Pvt. Ltd.
Owner: The Kasturi Family through Kasturi & Sons Ltd (KSL) & THG Publishing Pvt. Ltd.
Search & Explore
Search the news with more context, not more noise.
Today's Media Watch
Your daily guide to the stories shaping media, journalism, and public trust.
Who Owns the Narrative?
See the impact of media framing through real-world case studies.
The EU-Mercosur
Free-trade agreements divide opinion. The EU-Mercosur deal sparked conflicting headlines, reflecting debates over prices, industry, environment, and self-sufficiency.
COVID Vaccinations
This analysis of COVID vaccination coverage shows how ideology, ownership, and political framing shape media narratives, influencing both what we think and how we think.
Greenland
This case study explores the Greenland acquisition scenario as a real-world media literacy stress test, revealing how ideology, ownership, and political framing shape the stories we consume.
Learn About Our Fact-Based Transparency System
Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.
Learn more
